학술논문
A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer
Document Type
Article
Author
Rammensee, H.-G.; Chandran, P.A.; Zelba, H.; Rusch, E.; Gouttefangeas, C.; Kowalewski, D.J.; Di Marco, M.; Haen, S.P.; Walz, J.S.; Gloria, Y.C.; Bödder, J.; Laske, K.; Artzner, K.; Backert, L.; Schuster, H.; Weber, A.N.R.; Stevanović, S.; Löffler, M.W.; La Fougère, C.; Schwenck, J.; Pichler, B.J.; Kneilling, M.; Wiesmüller, K.-H.; Klein, R.; Schertel, J.-M.; Tunger, A.; Müller, L.; Kießler, M.; Wehner, R.; Schmitz, M.; Jakobi, M.; Schneiderhan-Marra, N.; Forchhammer, S.; Metzler, G.; Bauer, J.; Weide, B.; Schippert, W.
Source
In: Journal for ImmunoTherapy of Cancer . (Journal for ImmunoTherapy of Cancer, 15 November 2019, 7(1))
Subject
Language
English
ISSN
20511426